Axium QC-5-15-3DRecalls & reported problems
Micro Therapeutics, Inc. · QC-5-15-3D BARE AXIUM 3D COIL · Class 2 · Implant
All models of Axium (28)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00836462010376), received between Jan 28, 2019 and May 17, 2021 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
2 other recalls cover devices cleared under the same FDA submission (K081465); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Material Deformation1
- Separation Failure1
- Stretched1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 17, 2021Stretched; Detachment of Device or Device Component; Material Deformation; Stretched; Detachment of Device or Device Component; Material Deformation
MEDTRONIC RECEIVED A REPORT THAT THE GUIDE CATHETER AND MICROCATHETER WERE IN PLACE. THE AXIUM COIL BECAME STRETCHED/DAMAGED ON THE PROXIMAL SEGMENT OF THE PUSHWIRE AND WAS UNABLE TO BE IMPLANTED. THE COIL HAD BECOME DETACHED DURING USE. IT WAS NOTED THERE WAS NO FRICTION OR DIFFICULTY DURING TESTING OR DELIVERY, AND A CONTINUOUS FLUSH HAD BEEN ADMINISTERED. A REPLACEMENT PRODUCT WAS USED TO COMPLETE THE PROCEDURE. IT WAS INDICATED THAT ALL DEVICES WERE PREPARED AS PER THE INSTRUCTIONS FOR USE (IFU), AND NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF A SACCULAR, UNRUPTURED ANEURYSM OF THE ANTERIOR COMMUNICATING (ACOM) ARTERY WITH A MAX DIAMETER OF 3.7 MM AND A 2.9 MM NECK DIAMETER. IT WAS NOTED THE PATIENT'S BLOOD FLOW WAS NORMAL AND VESSEL TORTUOSITY WAS MODERATE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11837422 ↗MalfunctionJan 28, 2019Separation Failure; Separation Failure
MEDTRONIC RECEIVED INFORMATION THAT DURING A COILING PROCEDURE, THE COIL FAILED TO DETACH WITH AN INSTANT DETACHER AND MANUAL DETACHMENT (BREAKING HYPOTUBE METHOD; AN ALTERNATIVE METHOD PRESENTED IN THE INSTRUCTION FOR USE). THE COIL WAS POSITIONED INTO THE ANEURYSM WHEN IT FAILED TO DETACH. TWO DETACHMENT ATTEMPTS WERE MADE WITH THE INSTANT DETACHER AND THEN MANUAL METHOD WAS ATTEMPTED, BUT THE COIL DID NOT DETACH. THE COIL WAS REMOVED FROM WITHIN THE CATHETER. SUBSEQUENT COIL WAS USED TO TREAT THE PATIENT. NO PATIENT INJURY OCCURRED. THIS EVENT OCCURRED DURING THE TREATMENT FOR A SMALL RUPTURED SACCULAR ANEURYSM LOCATED IN LEFT POSTERIOR COMMUNICATING ARTERY, MEASURING 5MMX3MM. THE VESSEL ANATOMY WAS NORMAL. THE DEVICES WERE PREPARED AND USED PER THE INSTRUCTIONS FOR USE (IFU).
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8282025 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K081465. One submission often covers many models, so check the product and lot details in each record.
- Z-0874-2012 · Mar 1, 2010 · TerminatedAxium Detachable Coil System QC-7-30-Helix The ev3 Axium Detachable Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular a
- Z-0873-2012 · Mar 1, 2010 · TerminatedAxium Detachable Coil System QC-2-1-Helix The ev3 Axium Detachable Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular ab
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page